ATE481980T1 - Verfahren zur verabreichung eines thymosin-alpha 1 peptids - Google Patents
Verfahren zur verabreichung eines thymosin-alpha 1 peptidsInfo
- Publication number
- ATE481980T1 ATE481980T1 AT02802520T AT02802520T ATE481980T1 AT E481980 T1 ATE481980 T1 AT E481980T1 AT 02802520 T AT02802520 T AT 02802520T AT 02802520 T AT02802520 T AT 02802520T AT E481980 T1 ATE481980 T1 AT E481980T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- administration
- alpha
- thymosine
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33087401P | 2001-11-01 | 2001-11-01 | |
PCT/US2002/035093 WO2003037366A1 (en) | 2001-11-01 | 2002-11-01 | Method of administering a thymosin alpha 1 peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE481980T1 true ATE481980T1 (de) | 2010-10-15 |
Family
ID=23291672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02802520T ATE481980T1 (de) | 2001-11-01 | 2002-11-01 | Verfahren zur verabreichung eines thymosin-alpha 1 peptids |
Country Status (19)
Country | Link |
---|---|
US (2) | US20050049191A1 (de) |
EP (1) | EP1450850B1 (de) |
JP (1) | JP2005511563A (de) |
KR (1) | KR20050042229A (de) |
CN (1) | CN1582163A (de) |
AT (1) | ATE481980T1 (de) |
AU (1) | AU2002363248B2 (de) |
BR (1) | BR0213823A (de) |
CA (1) | CA2464307A1 (de) |
DE (1) | DE60237784D1 (de) |
EA (1) | EA008536B1 (de) |
ES (1) | ES2353379T3 (de) |
IL (2) | IL161665A0 (de) |
MX (1) | MXPA04004187A (de) |
NO (1) | NO327101B1 (de) |
NZ (1) | NZ532763A (de) |
PL (1) | PL208388B1 (de) |
UA (1) | UA80957C2 (de) |
WO (1) | WO2003037366A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL377376A1 (pl) * | 2002-11-25 | 2006-02-06 | Sciclone Pharmaceuticals, Inc. | Sposoby ochrony przed uszkodzeniem przez promieniowanie z użyciem Ó-tymozyny |
ATE467422T1 (de) * | 2003-03-28 | 2010-05-15 | Sciclone Pharmaceuticals Inc | Behandlung von aspergillus-infektionen mit thymosin alpha 1 |
US8017129B2 (en) | 2006-06-15 | 2011-09-13 | SciClone Pharmaceuticals International Ltd | Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |
US20080300166A1 (en) * | 2007-06-01 | 2008-12-04 | Sciclone Pharmaceuticals, Inc. | Treatment of Melanoma with Alpha Thymosin Peptides |
US20100317583A1 (en) * | 2007-12-14 | 2010-12-16 | Sciclone Pharmaceuticals, Inc. | Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa) |
WO2010129947A2 (en) | 2009-05-08 | 2010-11-11 | Sciclone Pharmaceuticals, Inc. | Alpha thymosin peptides as vaccine enhancers |
EP2838551A4 (de) * | 2012-03-08 | 2016-02-24 | Sciclone Pharmaceuticals Inc | Verwendung von thymosin alpha zur behandlung von eitriger rhinosinusitis |
US20130296223A1 (en) | 2012-03-30 | 2013-11-07 | Sciclone Pharmaceuticals, Inc. | Use of thymosin alpha for the treatment of sepsis |
EP3209321B1 (de) | 2014-10-21 | 2021-06-23 | SciClone Pharmaceuticals International Ltd. | Behandlung von krebs mit immunstimulatoren |
BR112017016205A2 (pt) * | 2015-02-09 | 2018-03-27 | Romani Luigina | thymosin alpha 1 para uso no tratamento de fibrose cística |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4447233A (en) * | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
TW224053B (de) * | 1991-09-13 | 1994-05-21 | Paul B Chretien | |
US5468729A (en) * | 1993-10-26 | 1995-11-21 | Alpha 1 Biomedicals | Method for treatment of autoimmune hepatitis |
US5760000A (en) * | 1994-05-13 | 1998-06-02 | University Technologies International,Inc. | Inhibition of liver cancer by the use of GnRH and GnRH analogs |
US5888980A (en) * | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
US5632983A (en) * | 1994-11-17 | 1997-05-27 | University Of South Florida | Method for treating secondary immunodeficiency |
US5849596A (en) * | 1996-07-08 | 1998-12-15 | Food Industry Research And Development Institute | Process for determining the smoke content of edible oil |
JP2004504585A (ja) * | 2000-07-14 | 2004-02-12 | トランスフォーム ファーマシューティカルズ,インコーポレーティッド. | 化合物の組織バリア輸送を最適にするためのシステムおよび方法 |
EP1343528A2 (de) * | 2000-11-02 | 2003-09-17 | Research Foundation of City University of New York | Methoden zur stimulierung der regeneration und reparatur des nervensystems durch hemmung der phosphodiesterase typ 4 |
-
2002
- 2002-01-11 UA UA20040504064A patent/UA80957C2/uk unknown
- 2002-11-01 WO PCT/US2002/035093 patent/WO2003037366A1/en active Application Filing
- 2002-11-01 US US10/493,848 patent/US20050049191A1/en not_active Abandoned
- 2002-11-01 ES ES02802520T patent/ES2353379T3/es not_active Expired - Lifetime
- 2002-11-01 AU AU2002363248A patent/AU2002363248B2/en not_active Ceased
- 2002-11-01 CN CNA02821871XA patent/CN1582163A/zh active Pending
- 2002-11-01 DE DE60237784T patent/DE60237784D1/de not_active Expired - Lifetime
- 2002-11-01 BR BR0213823-9A patent/BR0213823A/pt not_active IP Right Cessation
- 2002-11-01 PL PL370430A patent/PL208388B1/pl not_active IP Right Cessation
- 2002-11-01 MX MXPA04004187A patent/MXPA04004187A/es active IP Right Grant
- 2002-11-01 CA CA002464307A patent/CA2464307A1/en not_active Abandoned
- 2002-11-01 EP EP02802520A patent/EP1450850B1/de not_active Expired - Lifetime
- 2002-11-01 EA EA200400591A patent/EA008536B1/ru not_active IP Right Cessation
- 2002-11-01 NZ NZ532763A patent/NZ532763A/en not_active IP Right Cessation
- 2002-11-01 KR KR1020047006674A patent/KR20050042229A/ko not_active Application Discontinuation
- 2002-11-01 JP JP2003539708A patent/JP2005511563A/ja active Pending
- 2002-11-01 IL IL16166502A patent/IL161665A0/xx active IP Right Grant
- 2002-11-01 AT AT02802520T patent/ATE481980T1/de not_active IP Right Cessation
-
2004
- 2004-04-29 IL IL161665A patent/IL161665A/en not_active IP Right Cessation
- 2004-05-21 NO NO20042100A patent/NO327101B1/no not_active IP Right Cessation
-
2010
- 2010-05-07 US US12/775,986 patent/US20100221274A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002363248B2 (en) | 2007-11-22 |
MXPA04004187A (es) | 2004-07-08 |
NO327101B1 (no) | 2009-04-20 |
NO20042100D0 (no) | 2004-05-21 |
CN1582163A (zh) | 2005-02-16 |
US20050049191A1 (en) | 2005-03-03 |
CA2464307A1 (en) | 2003-05-08 |
EP1450850A1 (de) | 2004-09-01 |
UA80957C2 (en) | 2007-11-26 |
EP1450850B1 (de) | 2010-09-22 |
JP2005511563A (ja) | 2005-04-28 |
EA008536B1 (ru) | 2007-06-29 |
PL208388B1 (pl) | 2011-04-29 |
ES2353379T3 (es) | 2011-03-01 |
NZ532763A (en) | 2008-01-31 |
IL161665A0 (en) | 2004-09-27 |
WO2003037366A1 (en) | 2003-05-08 |
EP1450850A4 (de) | 2005-11-30 |
BR0213823A (pt) | 2004-08-31 |
PL370430A1 (en) | 2005-05-30 |
KR20050042229A (ko) | 2005-05-06 |
US20100221274A1 (en) | 2010-09-02 |
NO20042100L (no) | 2004-05-21 |
EA200400591A1 (ru) | 2004-10-28 |
DE60237784D1 (de) | 2010-11-04 |
IL161665A (en) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1626055A3 (de) | Nicht von Säugetieren stammende GnRH Analoga und deren Verwendung zur Regulierung des Immunsystems | |
MY132924A (en) | Hematopoietic stimulation | |
DE60327843D1 (de) | Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid | |
CA2376978A1 (en) | Compositions and methods for treatment of sexual dysfunction | |
MXPA05013340A (es) | Composiciones y metodos para liberacion mucosal incrementada de la hormona del crecimiento. | |
ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
MXPA05006572A (es) | Composiciones y metodos para la administracion mejorada por via mucosa de peptidos fijadores al receptor de y2 y metodos para tratar y prevenir la obesidad. | |
DE60237784D1 (de) | Verfahren zur verabreichung eines thymosin-alpha 1 peptids | |
US11433028B2 (en) | Compositions for treating viral infections and methods for same | |
DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
DE69615984D1 (de) | Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen | |
EA200400548A1 (ru) | Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi) | |
TR200101085T2 (tr) | Kronik hepatit C enfeksiyonlu hastalarda algılanabilir HCV-RNA'nın yok edilmesi için birleşik ribavirin-interferon alfa tedavisi | |
CN1917898B (zh) | 用于治疗间质肺部感染的血管活性肠肽的生物活性物质 | |
IT1317048B1 (it) | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie | |
ATE342276T1 (de) | Nährstoffe aus sojabohnenprotein | |
DE69834929D1 (de) | Verwendung eines organspezifischen ernährungmittels | |
ATE538782T1 (de) | Modifizierte aminosaeure 5-cnac zur hemmung der thrombozytenaggregation | |
HK1092162A1 (en) | Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt) | |
EA201000501A1 (ru) | Фармацевтическая композиция, содержащая не обладающий нейротоксичностью активатор плазминоген для лечения удара | |
DE602004007491D1 (de) | Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin | |
SE0200598D0 (sv) | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences | |
Binazzi | Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-Fluorouracil (5-FU) ointment | |
RU2001104929A (ru) | Способ лечения рассеянного склероза | |
RU2002113945A (ru) | Способ создания "новокаиновой подушки" для микросклерозирования |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |